Matches in Nanopublications for { ?s ?p "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP114207.RAZMRrqx74wQiE6IenC_6H2NbHJ5Z4NFX4CQTaY2lMTQI130_assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114207.RAZMRrqx74wQiE6IenC_6H2NbHJ5Z4NFX4CQTaY2lMTQI130_provenance.
- NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145712.RAjCnO1pxJDp-kJkwjFq_TyfDcbKvSem_uC-SfVHWGg5Q130_provenance.
- assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP177412.RAUV02CoIysSNzh9b52M4CIDo6fsiNsSkXQbM5qHcWWSA130_assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177412.RAUV02CoIysSNzh9b52M4CIDo6fsiNsSkXQbM5qHcWWSA130_provenance.
- NP208852.RAWlUnZL_imZ96Qldm1seCOmbSHL2bk4s21pLBmxp8WkQ130_assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208852.RAWlUnZL_imZ96Qldm1seCOmbSHL2bk4s21pLBmxp8WkQ130_provenance.
- NP213651.RAdqCYNF-BV-dNdR3azkKJ-jI_tAinHKSDPkaZYKAFR6A130_assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213651.RAdqCYNF-BV-dNdR3azkKJ-jI_tAinHKSDPkaZYKAFR6A130_provenance.
- NP213650.RAiUuoEu6LvURVI5htZL0j4DkAWR415cDLKldHgiXojYk130_assertion description "[The high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barrett's adenocarcinomas suggest that epigenetic inactivation may be critical in the development and progression of Barrett's esophagus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213650.RAiUuoEu6LvURVI5htZL0j4DkAWR415cDLKldHgiXojYk130_provenance.